Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies.
Genard G, Lucas S, Michiels C. · 2017
Read Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies. by Genard G, Lucas S, Michiels C. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5509958.txt.
Description
Genard, Lucas, and Michiels present a review in Frontiers in Immunology on tumor-associated macrophages. These immune cells can fill over half of a tumor's cell mass. Most lean toward a state that feeds tumor growth and spread. Flipping them to a tumor-fighting state could aid treatment. The review asks how standard therapies shift that balance.
Chemotherapy and immune therapies can each push macrophages toward the fighting state. Radiation can too, they report, though dose matters greatly. The pathways behind radiation's effect are traced in detail. Knowing the right dose could sharpen combined treatments. The authors call for trials built around this reprogramming idea.
Catalog record
| CREATOR | Genard G, Lucas S, Michiels C. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 108 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |